CIK: 1719678 - Address: C/O Iovance Biotherapeutics, Inc., 825 Industrial Road, 4Th Floor, San Carlos, CA 94070
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
4/17/24 19:08
4/15/24
IOVAIovance Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVogt Frederick GCAOInterim M.d00.0002117141D
3/6/24 18:19
3/4/24
IOVAIovance Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVogt Frederick GCAOInterim M.d00.0004248129D
1/18/24 18:09
1/16/24
IOVAIovance Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVogt Frederick GCAOInterim M.d00.000212799D
10/18/23 20:05
10/16/23
IOVAIovance Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVogt Frederick GCAOInterim M.d00.000213385D
7/17/23 18:22
7/14/23
IOVAIovance Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVogt Frederick GCAOInterim M.d00.000214073D
4/18/23 17:50
4/14/23
IOVAIovance Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVogt Frederick GCAOInterim M.d00.000215261D
1/19/23 16:51
1/17/23
IOVAIovance Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVogt Frederick GCAOInterim M.d00.0008349D
11/28/22 21:46
11/28/22
IOVAIovance Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVogt Frederick GCAOInterim P65.98011002D
6/2/22 20:00
6/1/22
IOVAIovance Biotherapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagVogt Frederick GCAOInterim P66.4401New1D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact